Legal aspects of botox administration
July 31st, 2012In a time when the professional bodies are clarifying and amending their guidance on how their registrants should conduct consultations for patients receiving cosmetic treatments, the pharmacies are also now clarifying legislation.
A major pharmacy has released a statement to all of their customers highlighting the importance of only prescribing items suitable and appropriate for that one patient. They brought attention to off label prescribing suggesting that Botox 50 would be more appropriate considering its licensed indication.
Another large pharmacy is now only accepting scripts for cosmetic medicine that stipulates that a face to face consultation has taken place. If they receive a script that does not specify this, they will not dispense against it.
The industry is under strict scrutiny at present according to the pharmacy and as always, if a HCP works against legislation or their professional guidance, their insurance will be invalidated.
